Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen

Applied Clay Science

Volumn 51, Issue 4, 2011, Pages 407-413

  Perioli, Luana ^a   Ambrogi, Valeria ^a   di Nauta, Laura ^a   Nocchetti, Morena ^a   Rossi, Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Dissolution; Flurbiprofen; Hydrotalcite; Nanostructured compound; Supersaturation

Indexed keywords

ACID CONDITIONS; ALKALINE CONDITIONS; CLASS II; DRUG CONTROLLED RELEASE; FLURBIPROFEN; GASTRIC FLUIDS; HYDROTALCITE; HYDROTALCITE-LIKE COMPOUND; HYDROTALCITES; INORGANIC MATERIALS; INORGANIC SOLIDS; INORGANIC-ORGANIC HYBRID MATERIALS; INTERLAYER REGIONS; MOLECULAR ANIONS; NANO-STRUCTURED; NANOSTRUCTURED SYSTEMS; NEW APPROACHES; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS;

BODY FLUIDS; DISSOLUTION; HYBRID MATERIALS; ION EXCHANGE; IONS; SOLUBILITY; SUPERSATURATION;

NANOCOMPOSITES;

DISSOLUTION; DRUG; HYDROTALCITE; NANOTECHNOLOGY; SOLUBILITY; SUPERSATURATION;

EID: 79952006937     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2010.12.019     Document Type: Article

References (27)

1. Ambrogi V., Fardella G., Grandolini G., Perioli L. Intercalation compounds of hydrotalcite-like anionic clay with antiinflammatory agents. Intercalation and in vitro release of ibuprofen. Int. J. Pharm. 2001, 220:23-32.
2. Ambrogi V., Fardella G., Grandolini G., Perioli L., Tiralti M.C. Intercalation compounds of hydrotalcite-like anionic clay with antiinflammatory agents. II. Uptake of diclofenac for a controlled release formulation. AAPS PharmSciTech 2002, 3:1-6. article 26 http://www.aapspharmscitech.org.
3. Ambrogi V., Fardella G., Grandolini G., Nocchetti M., Perioli L. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water solubile drugs. J. Pharm. Sci. 2003, 92:1407-1418.
4. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995, 12:413-420.
5. Bish D.L. Anion-exchange in takovite: applications to other hydroxide minerals. Bull. Mineral. 1980, 103:170-175.
6. Brouwers J., Brewster M.E., Augustijns P.J. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?. Pharm. Sci. 2009, 98:2549-2572.
7. Cavani F., Trifirò F., Vaccari A. Hydrotalcite-type anionic clays: preparation, properties and applications. Catal. Today 1991, 11:173-195.
8. Costantino U., Marmottini F., Nocchetti M., Vivani R. New synthetic routes to hydrotalcite-like compounds-characterisation and properties of the obtained materials. Eur. J. Inorg. Chem. 1998, 10:1439-1446.
9. Costantino U., Ambrogi V., Nocchetti M., Perioli L. Hydrotalcite-like compounds: versatile layered hosts of molecular anions with biological activity. Microporous Mesoporous Mater. 2008, 107:149-160.
10. Doi, N., Yonetani, A., Unno. T., 1989. Stable Topical Tolnaftate Preparations. Japanese Patent Kokai Tokkyo Koho, JP 01275527.
11. HyperChem ™, Release 6.01 for Windows, Molecular Modeling System, Distributed by Hypercube, Inc., Ontario, Canada (2000).
12. José dos Reis M., Silvério F., Tronto J., Valim J.B. Effects of pH, temperature, and ionic strength on adsorption of sodium dodecylbenzenesulfonate into Mg-Al-CO3 layered double hydroxides. J. Phys. Chem. Solids 2004, 65:487-492.
13. Jyothi T.M., Raja T., Rao B.S. Catalytic transfer reduction (CTR) of alkyl alkyl, alkyl aryl, cyclic and unsaturated ketones over calcined Mg-Al hydrotalcites. J. Mol. Catal. A Chem. 2001, 168:187-191.
14. Kim J.K., Kim M.S., Park J.S., Kim C.K. Thermo-reversible flurbiprofen liquid suppository with HP-β-CD as a solubility enhancer: improvement of rectal bioavailability. J. Incl. Phenom. Macrocycl. Chem. 2009, 64:265-272.
15. Klumpp E., Contreras-Ortega C., Klahre P., Tino F.J., Yapar S., Portillo C., Stegen S., Queirolo F., Scwuger M.J. Sorption of 2, 4-dichlorophenol on modified hydrotalcites. Colloid. Surf. A 2004, 230:111-116.
16. Löbenberg R., Amidon G.L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000, 50:3-12.
17. Miyata S. Anion-exchange properties of hydrotalcite-like compounds. Clay Clay Miner. 1983, 31:305-311.
18. Orlu M., Ceher E., Araman A. design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int. J. Pharm. 2006, 318:103-117.
19. Paradkar A., Maheshwari M., Tyagi A.K., Chauahan B., Kadam S.S. Preparation and characterization of flurbiprofen beads by melt solidification technique. AAPS PharmSciTech 2003, 4(4). article 65 http://www.aapspharmscitech.org.
20. Perioli L., Ambrogi V., Bertini B., Ricci M., Nocchetti M., Latterini L., Rossi C. Anionic clays for sunscreen agent safe use: photoprotection, photostability and prevention of their skin penetration. Eur. J. Pharm. Biopharm. 2006, 62:185-193.
21. Perioli L., Ambrogi V., Rossi C., Latterini L., Nocchetti M., Costantino U. Use of anionic clays for photoprotection and sunscreen photostability: hydrotalcites and phenylbenzimidazole sulfonic acid. J. Phys. Chem. Solids 2006, 67:1079-1083.
22. Shaw L.R., Irwin W.J., Grattan T.J., Conway B.R. The influence of excipient on the diffusion of ibuprofen and paracetamol in gastric mucus. Int. J. Pharm. 2005, 290:145-154.
23. Sinko P.J., Leesman G.D., Amidon G.L. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm. Res. 1991, 8:979-988.
24. Turco M., Bagnasco G., Costantino U., Marmottini F., Montanari G., Ramis G., Busca G. Production of hydrogen from oxidative steam reforming of methanol. II. Catalytic activity and reaction mechanism on Cu/ZnO/Al2O3 hydrotalcite-derivatives. J. Catal. 2004, 228:56-65.
25. U.S. Department of Health and Human Services-Food and Drug Administration-Center for Drug Evaluation and Research (CDER) Guidance for Industry - Waiver of In vivo Bioavailability and Bioequivalence Studies for Immediate-release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. (August 2000) http://www.fda.gov/cder/guidance/index.htm.
26. Wei M., Shi S., Wang J., Li Y., Duan X. Studies on the intercalation of naproxene into layered double hydroxide and its thermal decomposition by in situ FTIS and in situ HT-XRD. J. Solid State Chem. 2004, 177:2534-2541.
27. Winter F., Wolters M., Van Dillen A.J., De Jong K.P. A hydrotalcite-based catalyst system for the single-stage liquid-phase synthesis of MIBK. Appl. Catal. A 2006, 307:231-238.